AI Trends

Helios Uses Blood Proteins to Assess Disease Risk

Rohan PaulUpdated Nov 19 08:58

AI summary

Y Combinator startup Helios enables needle-free at-home collection of a single drop of blood to measure 1,000+ proteins, compared with the roughly 20 biomarkers checked in a routine physical; an AI agent then interprets the results and identifies which biomarkers indicate an increased risk of disease. Rohan Paul introduced the service with the hook: “An AI agent read all my emails this year, yet still knows nothing about my liver.”

Quoted post

Omar Abudayyeh

@omarabudayyeh

Introducing Helios: measuring 1,000+ protein biomarkers from a drop of blood to help you live younger, longer. Here’s how it works: • Self-collect blood at home with a painless, needle-free device • We measure the proteins carrying signals from cells and organs throughout your body • Your Helios AI agent explains your results, highlights risks, and offers personalized guidance Proudly backed by Y Combinator and Formation VC. Join the waitlist at https://t.co/ZFcLlzMFK2

View original

Introducing Helios: measuring 1,000+ protein biomarkers from a drop of blood to help you live younger, longer. Here’s how it works: • Self-collect blood at home with a painless, needle-free device • We measure the proteins carrying signals from cells and organs throughout your body • Your Helios AI agent explains your results, highlights risks, and offers personalized guidance Proudly backed by Y Combinator and Formation VC. Join the waitlist at https://t.co/ZFcLlzMFK2

View original post

Body

My AI agent has read every email I sent this year and still knows nothing about what my liver is doing.

Helios, a Y Combinator startup, lets you prick-free collect a drop of blood at home and measures 1,000+ proteins in it, where a routine checkup panel looks at about 20 markers.

An AI agent then reads those results and tells you which ones point to rising disease risk.

Source

Rohan Paul